This week we are going to discuss a relatively rare but painful condition called cervical dystonia or spasmodic torticollis. Cervical dystonia is a condition of adulthood that generally occurs after ...
NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and therapeutic conditions, today announced ...
SEATTLE -- A new botulinum toxin formulation kept cervical dystonia symptoms down for a solid 16 weeks in most patients treated in a manufacturer-sponsored phase III trial, a researcher said here.
After debuting in the aesthetics market with Daxxify last year, Revance has made its way to the potentially lucrative therapeutic space. With a Monday FDA nod to treat cervical dystonia in adults, ...
NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced positive topline results ...
The US Food and Drug Administration (FDA) has expanded the indiction for daxibotulinumtoxinA-lanm injection (Daxxify, Revance Therapeutics) for the treatment of cervical dystonia in adults, the ...
Add Yahoo as a preferred source to see more of our stories on Google. When we think of movement disorders, the tremors associated with Parkinson’s disease are probably what first spring to mind.
Shares of Revance Therapeutics Inc. RVNC gained 8% premarket on Monday after the U.S. Food and Drug Administration approved the biotech company’s Daxxify injection for treatment of cervical dystonia ...
NICE, France — Depression is the strongest long-term predictor of health-related quality of life (HR-QoL), followed by generalized anxiety disorder (GAD), for patients with isolated dystonia, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results